TMCnet News
WEALTHMAKERS.COM Issues Bullish Research Reports on IDIX, IMUC, SHLM, SHOR, TLAB, WD(M2 PressWIRE Via Acquire Media NewsEdge) WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), ImmunoCellular Therapeutics Ltd (OTCBB:IMUC), SCHULMAN (A) INC (NASDAQ:SHLM), Shoretel Inc (NASDAQ:SHOR), Tellabs Inc (NASDAQ:TLAB), Walker & Dunlop Inc (NYSE:WD) Click here to download each report: Idenix Pharmaceuticals Inc (NASDAQ:IDIX): http://www.wealthmakers.com/ireport/25672 ImmunoCellular Therapeutics Ltd (OTCBB:IMUC): http://www.wealthmakers.com/ireport/25683 SCHULMAN (A) INC (NASDAQ:SHLM): http://www.wealthmakers.com/ireport/25679 Shoretel Inc (NASDAQ:SHOR): http://www.wealthmakers.com/ireport/25673 Tellabs Inc (NASDAQ:TLAB): http://www.wealthmakers.com/ireport/25688 Walker & Dunlop Inc (NYSE:WD): http://www.wealthmakers.com/ireport/25698 WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients. Click here to LIKE us on Facebook: http://www.facebook.com/pages/WealthMakers-Ltd/165424826916060 Click here to FOLLOW us on Twitter: http://www.twitter.com/WealthMakersLtd Click here to access WealthMakers technology: http://www.wealthmakers.com/signup.html Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited. To learn more click here: http://www.buyins.com/woprbrochure.pdf WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf Idenix Pharmaceuticals Inc (NASDAQ:IDIX) - Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and Europe. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV). The company s HCV discovery program focuses on various classes of drugs, including nucleoside/nucleotide polymerase inhibitors, protease inhibitors, non-nucleoside polymerase inhibitors, and NS5A inhibitors. It develops products and drug candidates for the treatment of patients with hepatitis B virus (HBV), human immunodeficiency virus (HIV) type-1, and acquired immune deficiency syndrome (AIDS). The company principally has a collaboration agreement with Novartis Pharma AG for the development and commercialization of telbivudine, a drug for the treatment of HBV under the Tyzeka/Sebivo names. Idenix Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts. ImmunoCellular Therapeutics Ltd (OTCBB:IMUC) - ImmunoCellular Therapeutics, Ltd., a clinical stage biotechnology company, focuses on developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumor cancers. Its product candidate portfolio consists of cellular immunotherapies targeting cancer and cancer stem cell antigens; peptide based immunotherapies targeting cancer stem cells; and monoclonal antibodies to diagnose and treat cancers, such as such as glioblastoma multiforme (GBM), ovarian cancer, small-cell lung cancer, and pancreatic cancer. The company s lead product candidate, ICT-107, is a dendritic cell-based vaccine that is in Phase II clinical trial targeting multiple tumor associated antigens for GBM, a particularly lethal type of brain cancer. It also engages in developing ICT-121, a CD-133 targeting cancer stem cell vaccine in pre-clinical development stage to treat GBM, pancreatic cancer, and other solid tumor cancers; and ICT-140, a dendritic cell-based vaccine targeting cancer stem cells and cancer antigens in pre-clinical development stage for the treatment of ovarian cancer. In addition, the company is developing various monoclonal antibody product candidates, including ICT-109, ICT-037, ICT-69, and ICT-Diagnostic-SCLC, which are in pre-clinical development stage to treat small cell lung cancer, lung and colon cancer, pancreatic cancer, multiple myeloma, and ovarian cancer. ImmunoCellular Therapeutics, Ltd. is based in Woodland Hills, California. SCHULMAN (A) INC (NASDAQ:SHLM) - A. Schulman, Inc. supplies plastic compounds and resins for packaging, automotive, consumer products, and industrial applications. It offers additive compounds, carbon black color concentrates, white color concentrates, additive compounds for polyester resins and special pearl effects, antistatic concentrates, custom color concentrates for film and molding, absorptive concentrate to reduce odorsl, and masterbatch for the production of synthetic paper. The company also provides engineered plastics, including thermoplastic elastomers and vulcanizates, filled and unfilled nylon and PBT compounds, nylon/ABS alloys, formulated ionomer compounds, thermoplastic ionomer resins, flame-retardant thermoplastic compounds and concentrates, thermoplastic olefins, flexible thermoplastic PVC compounds, filled and unfilled acetal compounds, ABS compounds and alloys, and renewable natural fiber-filled thermoplastics, as well as polypropylene, polyethylene, and EVA compounds. In addition, it offers custom color and specialty compound powders, rotational molding process compounds, cross-linkable resin used in rotational molding, and high heat-distortion temperature materials. Further, the company provides jet milling services used for products requiring very fine particle size, such as additives for printing ink, adhesives, waxes, and cosmetics; cryogenic milling services for heat sensitive materials; and tolling services. Additionally, it buys, repackages, and re-sells polymers for various processing types comprising injection molding, blow molding, thermoforming, and film and sheet extrusion. The company s products are also used in a range of markets, such as mobility, building and construction, electronics and electrical, agricultural, personal care and hygiene, sports and leisure, custom services, and others. The company has operations in the Middle East, Africa, the Americas, Europe, and the Asia Pacific. A. Schulman, Inc. was founded in 1928 and is headquartered in Akron, Ohio. Shoretel Inc (NASDAQ:SHOR) - ShoreTel, Inc., together with its subsidiaries, engages in the development and sale of Internet protocol (IP) communications systems for enterprises in the United States and internationally. The company s systems are based on its distributed software architecture and switch-based hardware platform that enable multi-site enterprises to be served by a single telecommunications system. Its solutions include ShoreTel IP Phones; ShoreTel Voice Switches; ShoreTel Service Appliances; ShoreTel Director, which enables IT administrators to view and manage the entire system of the enterprise from any location using a single application; Unified Messaging solutions that enables users to obtain voice mail messages from various devices; Automated Attendant, which enables the enterprise to direct callers to appropriate individuals, workgroups, or messages; and Small Business Edition solution for smaller enterprises. The company also provides ShoreTel Communicator, which enables the integration of IP telephony solutions with instant messaging, desktop collaboration, and video; Microsoft Integration; ShoreTel Contact Center that enables organizations to route incoming contacts to appropriate agent in a multisite contact center; and ShoreTel Mobility for smartphone users that allows the user to communicate from any location, including office, home, or through Wi-Fi hotspots. In addition, it offers custom application development, integration, and implementation services for businesses; and post-contractual support, training, system design and installation, and professional services. The company sells its products to small, medium, and large companies, as well as public institutions in various markets, including the professional services, financial services, government, education, healthcare, manufacturing, non-profit organization, and technology through a network of distributors. ShoreTel, Inc. was founded in 1996 and is headquartered in Sunnyvale, California. Tellabs Inc (NASDAQ:TLAB) - Tellabs, Inc. designs, develops, and supports telecommunications networking products for communication service providers in the United States and internationally. Its products and services enable customers to deliver wireless and wireline voice, data, and video services to business and residential customers. The company operates through three segments: Broadband, Transport, and Services. The Broadband segment provides access products that enable service providers to deliver bundled voice, video, and high-speed Internet/data services over copper or fiber networks; managed access products, which deliver wireless and business services primarily outside of North America; and data products, including packet-switched products that enable wireless and wireline carriers to deliver mobile voice and Internet services, and wireline business services to their customers. The Transport segment enables service providers to manage network bandwidth by adding capacity needed; and wireline and wireless providers to support metro networks, mobile services, and business services for enterprises, as well as triple-play voice, video, and data services for residential consumers. The Services segment delivers deployment, training, support, and professional services, which support various phases of the network, such as planning, building, and operating. Tellabs, Inc. serves primarily communication services providers, including local exchange carriers; wireline and wireless service providers; multiple system operators; competitive service providers; distributors; original equipment manufacturers; system integrators; and government agencies. The company sells its products and services through its direct sales and sales support personnel, value-added resellers, independent sales representatives, distributors, and public and private network providers. Tellabs, Inc. was founded in 1974 and is headquartered in Naperville, Illinois. Walker & Dunlop Inc (NYSE:WD) - Walker & Dunlop, Inc., through its subsidiaries, provides commercial real estate financial services for owners and developers of commercial real estate in the United States. The company originates, sells, and services a range of multifamily properties; and offers a range of commercial real estate finance products, including first mortgage loans, second trust loans, supplemental financings, construction loans, mezzanine loans, bridge/interim loans, and equity investments under the GSE and HUD programs. It also provides multifamily finance for multifamily, manufactured housing communities, student housing, and healthcare properties under the Fannie Mae DUS program; and FHA finance, such as construction and permanent loans to developers and owners of multifamily housing, senior housing, and healthcare facilities. In addition, the company offers healthcare finance products for skilled nursing facilities and hospitals; and acts as an intermediary in the placement of commercial real estate debt between institutional sources of capital, which include life insurance companies, investment banks, commercial banks, pension funds, and other institutional investors, and owners of various types of commercial real estate. Further, it provides advises on capital structure; develops the financing package; facilitates negotiations between its client and institutional sources of capital; coordinates due diligence; and assists in closing the transaction. Additionally, the company offers interim loan program that offer floating-rate debt for borrowers to acquire or reposition multifamily properties, as well as services and asset-manages loans; and investment consulting and related services for commercial real estate funds. Walker & Dunlop, Inc. is headquartered in Bethesda, Maryland with additional offices in Atlanta, Georgia; Chicago, Illinois; Dallas, Texas; Irvine, California; Nashville, Tennessee; New Orleans, Louisiana; New York, New York; and Walnut Creek, California. About WEALTHMAKERS Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction! Strategies include: EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports. FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential. GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data. GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality. PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move. EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements. RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers. SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably. VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly. INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge. DISCLAIMER: WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures. Contact: WEALTHMAKERS 1-516-858-1113 [email protected] www.wealthmakers.com CONTACT: WealthMakers Tom Ronk [email protected] http://www.WealthMakers.com ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected])). (c) 2013 M2 COMMUNICATIONS |